Federico Carbone is MD PhD, Associate professor at University of Genoa (Italy) and Consultant in Internal Medicine at IRCSS Ospedale Policlinico San Martino in Genoa, Italy. The mindset of Federico Carbone is that typical of Internal Medicine: Open and curious. He started his creeper in 2013 investigating the role of inflammation in atherosclerosis and myocardial infarction during his PhD period at University of Geneva (Switzerland). He then broadened their interest toward inflammation in different fields, mainly cardio metabolic disorders but also, infectious disease and malignancies. Such an open view continuously paves the way for future investigations. Federico Carbone now focus of obesity, reverse cardio-oncology and is the leading worldwide expert of ostepontin. Federico Carbone published more than 200 articles in peer-reviewed Journals from 2013. In half of them he was first/last/corresponding author. He reached a citation number of 6760 in Google Scholar with a H-index of 46. Federico Carbone joined the Council of the European Society for Clinical Investigation in 2018 and now serves as vice-president of the Society. In this role he was invited speaker/workshop organizer in 7 annual scientific meeting of the society and is congress organizer for the year 2025. Federico Carbone is also deputy editor of the peer-reviewed Journal European Journal of Clinical Investigation and editorial board member of the Journals Nutrients, Biomolecules, BioMed Research International and Frontiers in Cardiovascular Medicine. He is also member of the italian/european associations for the study of diabetes, member of the Italian Societies of Internal Medicine and Atherosclerosis. As documented in ORCID and Publons, Federico Carbone have actively contributed as referees to relevant peer-reviewed Journals, including European Heart Journal, Thrombosis and Haemostasis, European Journal of Clinical Investigation, PlosOne, BioMed Research International, BMC cardiovascular disorders, American Journal of Pathology, International Journal of Cardiology, Experimental Gerontology, Nutrition Metabolism and Cardiovascular disease, Hypertension, Diabetes. Federico Carbone has reached a significant role in the panorama of cardiometabolic disease especially in the identification of dedicated bioamarkers such as osteopontin. Now engaged in the "reverse cardio-oncology", his long term gola is to link cardiometabolic disease and malignancy under the same umbrella of senescence. Due to the strong commitment in clinical duties, Federico Carbone has developed strong interpersonal, management and problem-solving skills. Working in an university hospital also allowed him to develop mentoring skills in the relationship with residents, PhD and post-doctoral scientists. Federico Carbone has a brilliant life out of work. Book and football lover, he spends a lot of time with his daughters and in beer production (SCI).